Based on TMEM-family genes (TMEMs), we developed and validated the signatures of four genes, TMEM106C, TMEM201, TMEM164, and TMEM45A, for prognosis and risk classification in HCC patients. The gene discussed is TMEM106C; the disease is hepatocellular carcinoma.